Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients.
Donmez-Altuntas H, Bayram F, Coskun-Demirkalp AN, Baspınar O, Kocer D, Toth PP. Donmez-Altuntas H, et al. Among authors: toth pp. Exp Biol Med (Maywood). 2019 Oct;244(13):1089-1095. doi: 10.1177/1535370219871895. Epub 2019 Aug 19. Exp Biol Med (Maywood). 2019. PMID: 31426681 Free PMC article.
Prevalence of dyslipidemia and associated risk factors in Turkish adults.
Bayram F, Kocer D, Gundogan K, Kaya A, Demir O, Coskun R, Sabuncu T, Karaman A, Cesur M, Rizzo M, Toth PP, Gedik V. Bayram F, et al. Among authors: toth pp. J Clin Lipidol. 2014 Mar-Apr;8(2):206-16. doi: 10.1016/j.jacl.2013.12.011. Epub 2014 Jan 19. J Clin Lipidol. 2014. PMID: 24636181
Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis.
Awad K, Serban MC, Penson P, Mikhailidis DP, Toth PP, Jones SR, Rizzo M, Howard G, Lip GYH, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Awad K, et al. Among authors: toth pp. J Clin Lipidol. 2017 Jul-Aug;11(4):972-985.e9. doi: 10.1016/j.jacl.2017.06.001. Epub 2017 Jun 13. J Clin Lipidol. 2017. PMID: 28826569 Review.
Novel Therapeutic Targets for Managing Dyslipidemia.
Sathiyakumar V, Kapoor K, Jones SR, Banach M, Martin SS, Toth PP. Sathiyakumar V, et al. Among authors: toth pp. Trends Pharmacol Sci. 2018 Aug;39(8):733-747. doi: 10.1016/j.tips.2018.06.001. Epub 2018 Jun 30. Trends Pharmacol Sci. 2018. PMID: 29970260 Review.
Statins: Then and Now.
Toth PP, Banach M. Toth PP, et al. Methodist Debakey Cardiovasc J. 2019 Jan-Mar;15(1):23-31. doi: 10.14797/mdcj-15-1-23. Methodist Debakey Cardiovasc J. 2019. PMID: 31049146 Free PMC article. Review.
Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).
Bayram F, Sonmez A, Haymana C, Sabuncu T, Dizdar OS, Gurkan E, Carlioglu AK, Agbaht K, Ozdemir D, Demirci I, Barcin C, Salman S, Tetiker T, Balci MK, Kebapci N, Ersoy C, Yumuk V, Toth PP, Satman I; TEMD Study Group. Bayram F, et al. Among authors: toth pp. Lipids Health Dis. 2020 Nov 11;19(1):237. doi: 10.1186/s12944-020-01408-2. Lipids Health Dis. 2020. PMID: 33176832 Free PMC article.
SPARCL: the glimmer of statins for stroke risk reduction.
Armani A, Toth PP. Armani A, et al. Among authors: toth pp. Curr Atheroscler Rep. 2007 Nov;9(5):347-51. doi: 10.1007/s11883-007-0044-1. Curr Atheroscler Rep. 2007. PMID: 18001616 Clinical Trial.
431 results